Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis

4 April 2025 (11:00 - 11:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Valeria Chiara Lanari

Milan (Italy)

5 More presentations in this session

Presentation thumbnail

Gender differences in the management of dyslipidemia in Switzerland

Doctor R. de La Harpe (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Prevalence and clinical relevance of familial hypercholesterolemia-causing mutations in Germany

Doctor N. Arnold (Hamburg, DE)

Abstract Slides

Presentation thumbnail

More musculoskeletal disorders and poor pain management in patients with familial hypercholesterolemia and self-perceived side effects to cholesterol-lowering treatment

Ms A. Uduma (Oslo, NO)

Abstract Slides

Presentation thumbnail

Monetary costs and LDL-C reduction from upfront combination lipid-lowering therapy with ezetimibe in an irish ACS cohort

Doctor D. Butler (Galway, IE)

Abstract Slides

Presentation thumbnail

Evaluation of LDL levels and lipid optimisation in high cardiovascular risk patients in nurse-led clinics in Ireland: a cross-sectional study

Mrs M. Brennan (Waterford, IE)

Abstract Slides

Access the full session

Session thumbnail

Dyslipidaemia management in 2025: status quo and best practice (2)

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 11:00 CET

You may be interested in

Congress Presentation

Where are we now? Decision-making in LDL-C lowering and CV risk

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Congress Presentation

2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources